Tower Research Capital (TRC)’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-177
| Closed | -$1K | – | 6342 |
|
2021
Q1 | $1K | Sell |
177
-1,752
| -91% | -$9.9K | ﹤0.01% | 5345 |
|
2020
Q4 | $6K | Buy |
+1,929
| New | +$6K | ﹤0.01% | 4595 |
|
2020
Q3 | – | Sell |
-1,404
| Closed | -$7K | – | 5354 |
|
2020
Q2 | $7K | Buy |
+1,404
| New | +$7K | ﹤0.01% | 4190 |
|
2017
Q4 | – | Sell |
-2
| Closed | – | – | 4427 |
|
2017
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4453 |
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 5332 |
|
2015
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5373 |
|
2015
Q2 | – | Sell |
-4
| Closed | -$1K | – | 5366 |
|
2015
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 4219 |
|
2014
Q4 | – | Sell |
-4
| Closed | -$1K | – | 5029 |
|
2014
Q3 | $1K | Buy |
4
+2
| +100% | +$500 | ﹤0.01% | 4222 |
|
2014
Q2 | $1K | Sell |
2
-20
| -91% | -$10K | ﹤0.01% | 3831 |
|
2014
Q1 | $10K | Sell |
22
-55
| -71% | -$25K | ﹤0.01% | 2636 |
|
2013
Q4 | $37K | Buy |
77
+64
| +492% | +$30.8K | 0.01% | 1671 |
|
2013
Q3 | $6K | Sell |
13
-47
| -78% | -$21.7K | ﹤0.01% | 3592 |
|
2013
Q2 | $28K | Buy |
+60
| New | +$28K | ﹤0.01% | 1412 |
|